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Prejunctional receptors modulating noradrenaline release from sympathetic nerves have
been studied extensively during the last two decades. Most evidence supporting a modulatory
role for these receptors has been obtained from studies using isolated tissues, in situ ptfuseÀ
organs, pithed animals or anaesthetized animals. In this thesis two different models were used
to study the in viyo function and capacity of prejunctional auto- and heteroreceptors
modulating endogenous noradrenaline overflow in the vasculature of freely moving rats.
Firstly, the local modulation of electrically evoked noradrenaline overflow through
nreiunctional receptors in the portal vein was studied. For this purpose Wistar rats were
permanently instrumeritei, 'w;Íb, z bioolar stimulation electrode around the vein, located
between two cannulas, one for the infusion of drugs (upsrearr| zfd anÊ for the sampling of
blood, placC downstream of the first cannula. Biphasic pulses of 2 Hz, 3 msec and 5 mA
were used to stimulate the nervous plexus of the portal vein to elicit the release of
noradrenaline. Infusion of drugs through the infusion cannula allowed the locat appiitzlicr. cf
drugs modulating the elertncally evoked noradrenaline overflow. In some studies, an
additional cannula was inserted in the abdominal aorta, enabling simultaneous measurement of
blood pressure and heart rate (chapters 2-O.
Secondly, the physiological role of prejunctional receptors modulating exercise-induced over-
flow of noradrenaline was studied. The rats used in this study were permanently instrumented
with a sampling cannula placed in the right jugular vein and an infusion cannula in the left
jugular vein. Swimming exercise, a physiological way of activating the sympathetic nervous
system, was used to elicit the release of noradrenaline. The rats were forced to swim against
a counter current for 20 minutes, while blood samples were taken to establish changes in nor-
adrenaline levels. Adrenodemedullated animals were used to prevent adrenaline release from
the adrenal medulla to interfere with the prejunctional receptors studied (chapter 7 and E).
1 1 6 Swnnnrl,
'I'he capacity of angiotensin II as a hormonal modulator activating prejunctional receptors
facilitating no;adrenaline overflow was studied in chapter 2. Local infusion in the portal vein
of angiotensin II (0.1, 0.5 and 1 pglkg/min) induced a pronounced increase of both basal and
electrically evoked noradrenaline overflow (upto 213% and 209%, respectively). The
angiotensin II receptor antagonisÍ saralasin (10 pglkg/min) completely reversed these effects,
showing the presence of facilitatory prejunctional angiotensin II receptors. Angiotensin II has
also been proposed to act as a local transjunctional modulator of noradrenaline release.
Posdunctional activation of 8r-adrenoceptors has been suggested to activate the local vascular
fr:rmation and release of angiotensin II. Since both the Br-adrenoceptor agonist fenoterol (0.25
mg/kg) and angiotensin II induced a strong facilitation of the electrically evoked
noradrenaline overflow, part of the effect of fenoterol might be due to the mechanism
described above. Inhibition of angiotensin II synthesis using captopril (10 mg/kg) or blockade
of prejunctional angiotensin II receptors using saralasin, however, did not change the
faciiitation of both basal and electrically evoked noradrenaline overflow induced by fenoterol,
indicating no transjunctional modulatory role of angiotensin II in the Br-adrenoceptor
facilitated noradrenaline release in the portal vein.
On the other hand posdunctional receptor activation by fenoterol and angiotensin II,
however, did induce marked changes in mean arterial pressure. Changes in blood pressure
induce a baroreceptor reflex mediated alteration in sympathetic nerve activation which will
lead to changes in heart rate and plasma noradrenaline independent of prejunctional receptors
(chapter 3). To study the possible interference of the baroreceptor eflex on the prejunctional
effects of fenoterol and angioiensin II, the effects of the vasodilator sodium nitroprusside
(2.5 pglkglmin) and the vasoconstrictor phenylephrine (2.5 pglkglmin), which are both
devoid of a prejunctional action, were studied. Both compounds did not change the
electrically evoked noradrenaline overflow, showing that the facilitation of evoked overflow
by fenoterol and angiotensin lI, is solely due to local prejunctional í!-adrenergic and
angiotensin II receptors. The enhancenrent of basal noradrenaline concentration, rvhich is
derived from numerous peripheral sympathetic junctions, by fenoterol and angiotensin II,
however, is strengthened or dampened, respectively, by baroreceptor eflex-mediated changes
in sympatlretic nerye activity,
The influence of the co-transmitter neuropeptide Y (NPY), known as a co-transmitter of
noradrenaline, on electrically evoked noradrenaline overflow was studied in chapter 4.
Infusion of NPY (2-2004 nglkglmin) showed that prejunctional NPY receptors are able to
inhibit almost cornpletely the electrically evoked noradrenaline overflow. Infusion of the
Y,-selective agonist [-eu3r,Pro34]NPY and the Yr-selective agonist NPY-(18-36), suggested a
prejunctionai heterogeneity of both Y, and Y, receptors. 1Leu3t,Pro34lNPY even showed a
biphasic inhibition pattern. It was suggested that the potent inhibition of evoked noradrenaline



































facil i l i






fusion in the portal vein
crease of both basal and
)%, respectively). The
7 reversed these effects,
rtors. Angiotensin II has
' noradrenaline release.
tivate the local vascular
r agonist fenoterol (0.25
he electrically evoked
due to the mechanism
(10 mg/kg) or blockade
r, did not change the
w induced by fenoterol,
in the Br-adrenoceptor
:ol and angiotensin Il,
urges in blood pressure
e activation which will
prejunctional receptors
lex on the prejunctional
r sodium nitroprusside
min), which are both
did not change the
rn of evoked overflow
nal íl-adrenergic and
)ncentration, which is
rl and angiotensin II,
:flex-mediated changes
as a co-transmitter of
iudied in chapter 4.
receptors are able to
low. Infusion of the
'-(18-36), 
suggested a
NPY even showed a
evoked noradrenaline
ptors.
The subsequent 4 chapters discuss the role of adrenaline as a co-transmitter of
noradrenaline. Infusion of 100 ng/min adrenaline for two hours in adrenodemedullated rats,
followed by an interval of one hour, in which the plasma adrenaline concentration returned to
undetectable levels, resulted in an enhancement of electrically evoked noradrenaline of 194%
of control (saline infusion). Furthermore adrenaline was also released, together with
noradrenaline, resulting in total catecholamine overflow upto 258% of control (chapter 5).
This facilitatory effect of adrenaline on the electrically evoked overflow is mediated through
prejunctional Br-adrenoceptors since it could be blocked by the selective íl-adrenoceptor
antagonist ICI 118,551 (0.3 mg/kg). The neuronal uptake blocker cocaine (2.5 mg/kg plus
0.05 mg/kg/min) infused together with adrenaline prevented the evoked release of adrenaline
as well as facilitation of the evoked overflow, revealing the neuronal origin of the adrenaline
released. ar-Autoreceptor blockade with yohimbine (0.5 mg/kg) after adrenaline infusion
further augmented the evoked overflow of noradrenaline plus adrenaline. It was concluded
that adrenaline can be taken up by sympathetic nerve terminals via cocaine sensitive uptake
carriers and is released during nerve stimulation to facilitate neurotransmitter overflow
through activation of prejunctional Br-receptors.
Two different doses of adrenaline (20 and 100 ng/min) were used in chapter 6 to study
the duration of the facilitatory effects of co-released adrenaline. Both doses of adrenaline
enhanced electrically evoked noradrenaline overflow to the same extent, indicating the
involvement of inhibitory prejunctional d2-autoreceptors at the highest dose used. Repeated
stimulation after 24 h, 48 h and 72 h showed that co-released adrenaline from sympathetic
nerve terminals is able to facilitate noradrenaline overflow upto 48 hours after administration.
These effects could be blocked by ICI 118,551 (0.3 mgikg) showing again the involvement of
prej unctional Br-adrenoceptors.
The effect of exogenously applied adrenaline (100 ng/min, administered as in chapters 5
and 6), taken up and released from sympathetic nerves, on the swimming exercise induced
noradrenaline overflow in adrenodemedullated Wistar rats was studied in chapter 7. As
during electrical stimulation, swimming exercise induces the release of adrenaline after
preloading. During the first 3 min of swimming the overflow of noradrenaline and adrenaline
was enhanced to 178% of control (saline infusion). During the whole 20 minutes of
swimming exercise, the enhancement of the overflow of both catecholamines was slightly less
(upto 165%). Cocaine, in the same dose as above, again blocked the uptake and release of
adrenaline as well as its facilitatory effect. Yohimbine (0.25 mg/kg) further enhanced the
facilitatory effect of co-released adrenaline which could be blocked by ICI 118,551
(1.0 mg/kg). The results showed that also during a physiological activation of the sympathetic
nervous system, like swimming exercise, adrenaline can be released as a co-transmitter and is
able to markedly facilitate the noradrenaline (and adrenaline) overflow through prejunctional
Br-adrenoceptors.
l]-q_- ___,Suntnt-am*
In chapter E the role of adrenaline and ttre occurrence of prejunctional receptor aiterations
in the development of hypertension in the spontaneously hypertensive rat (SHI?") were studietl
using the same experimental protocoi as in chapter 7. The SHR is a widely r-rsed model of
human essential hypertension. Hypertension starts to develop in these anintals from tlte Js
week of age on. A,drenodemeduliation at this age was shown to attenuate the development of
tlyp€rtension. SHR demedullated at 4 weeks of age (SHR-ADM4) responded to swinrming
exercise very similar as normotensive aclrenoclemedullated Wistar rats (Wtr{ADM), both after
saline and after adrenaline í100 ng/rnin) inlïsion. l{owever. SFIR, adrenodernedullated at 1ó
weeks (SHR-ADM16) hacl enharrced responsiveness, resulting in a strongly elevated exercise
induced noradrenaline (and adrenaline) overflow, indicating that atlrenalirte plays an important
role in the genesis ot this tbrrn of genetic hypertension as far as sympathetic
neurr:transmission is involved. T'he relative contribution of the prejunctional 0r-adrenoceptor
mediated enhancement of noradrenaline overflow by co-released adrenaline during swimming,
however, was similar in all rats studied. Administration of yohimbine (0.25 mg/kg) revealed
that in SHR-ADM16, in contrast to SHR-ADM4 and normotensive Wistar rats, inhibitory
crr-adrenoceptors were partially defective, resulting in enhanced noradrenaline and adrenaline
overflow during exercise, particularly during the first 3 minutes of swimming. The results
indicate that adrenaline may play an important role in the initiation of hypertension at a
critical stage of enhanced Br-adrenoceptor responsiveness in young prehypertensive SHR.
whereas subsensitive prejunctional or-adrenoceptors may play a role in the maintenance of
hypertension.
In conclusion, both models of local and general noradrenaline overÍ'low used in this thesis
have proven very useful in the study of the physiological function of prejunctional receptors
modulating endogenous noradrenaline overflow in vivo. Locally released co-transmitters, like
NPY and adrenaline, probably play an important role in the modulating of noradrenaline
release and consequently in the regulation of local vascular tension and eventually in the
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